ID   PEA
AC   CVCL_UD53
DR   Wikidata; Q98128531
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 72 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
RX   PubMed=1997098; DOI=10.1038/bjc.1991.52; PMCID=PMC1971782;
RA   Lee, Francis Y.F.
RA   Flannery, Deborah Jean
RA   Siemann, Dietmar W.
RT   "Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by
RT   a glutathione-targeted assay.";
RL   Br. J. Cancer 63:217-222(1991).
//
RX   PubMed=2789934; DOI=10.1038/bjc.1989.273; PMCID=PMC2247186;
RA   Lee, Francis Y.F.
RA   Siemann, Dietmar W.
RA   Sutherland, Robert M.
RT   "Changes in cellular glutathione content during adriamycin treatment
RT   in human ovarian cancer -- a possible indicator of chemosensitivity.";
RL   Br. J. Cancer 60:291-298(1989).
//
RX   PubMed=3182331; DOI=10.1016/0360-3016(88)90127-7;
RA   Rofstad, Einar K.
RA   Sutherland, Robert M.
RT   "Radiation sensitivity of human ovarian carcinoma cell lines in vitro:
RT   effects of growth factors and hormones, basement membrane, and
RT   intercellular contact.";
RL   Int. J. Radiat. Oncol. Biol. Phys. 15:921-929(1988).
//